Biomedicine
Phase 2 of Singapore's Biomedical Sciences Initiative gains momentum for clinical research
Published in Medical Letter on the CDC and FDA, November 4th, 2007
A new partnership to build an integrated neuroscience research programme that spans basic science all the way to clinical research. Strategic research infrastructure for tertiary hospitals and medical schools, and a national organisation to support and strengthen late phase clinical trials in Singapore. These are some of the new initiatives that were endorsed by the Biomedical Sciences International Advisory Council (BMS IAC) at their annual meeting. These initiatives will boost Singapore's translational and clinical research (TCR) capabilities which is the focus of our Biomedical Sciences (BMS) Initiative Phase 2.
This year's BMS IAC meeting was the 12th since the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Cancer Vaccines
Baylor Research Institute to Collaborate with Mount Sinai School of Medicine to Develop Therapeutic Cancer Vaccines - HIV/AIDS
HIV-Infected Children in Africa Who Receive Care in Primary Health Care Pediatric Treatment Programs Can Have Good Outcomes - Malaria Vaccines
New Lancet study: Malaria vaccine candidate has promising safety, tolerability profile in infants - Pharmacological
European drug regulations need to change, say experts - West Nile Virus
West Nile Virus' Spread Through Nerve Cells Linked to Serious Complication - Acute Promyelocytic Leukemia
INNOVIVE Pharmaceuticals Announces Receipt of FDA Orphan Drug Designation for Tamibarotene for the Treatment of Acute Promyelocytic Leukemia - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
